Prior to this role, Jay earned his PhD in Electrical Engineering from Purdue University, where he led a collaborative team of physicians and engineers to develop a closed-loop, implantable device for treating glaucoma, leveraging an application-specific integrated circuit (ASIC) that he designed to achieve this functionality. Concurrently, he worked at Bionode Inc., a medical device startup in ophthalmology, where he led clinical studies and product development to advance the company’s novel contact lens system delivering electroceutical therapy for glaucoma toward commercialization. Earlier in his career, Jay was part of the R&D team at Cyberonics (now LivaNova) in Houston, TX, contributing to ensuring the company’s neuromodulation system for treating epilepsy met updated standards for MRI-induced heating. He received a B.S. in Biomedical Engineering from The University of Texas at Austin.

Prior to this role, Vivek earned his PhD in Electrical Engineering from Purdue University, where he developed a closed-loop implantable electroceutical device to monitor gastric electrophysiological signals in both chronic and acute models. He led product development and delivered on an ambitious technology roadmap in a highly collaborative team of scientists, electrophysiologists and physicians at major institutions like the Florey Institute in Melbourne. Earlier in his career, Vivek worked at a cutting edge diagnostic technology startup, overseeing the launch of its flagship single-photon based product to pilot customers. Vivek also worked in the Health Technologies team at Apple Inc. in Cupertino, contributing to the development of new hardware and health features of the Series 1 Apple Watch. He received a B.S. in Biomedical Engineering and a minor in Electrical Engineering from Purdue University.

Prior to this role, Trevor earned his Ph.D. in Electrical Engineering from Johns Hopkins University where he focused on signal processing and machine learning, including developing novel deep learning architectures for seizure prediction and implementing them on low-power implantable device platforms. Additionally, he worked on multimodal analysis methods in Parkinson's and Alzheimer's disease patients, as well as novel functional imaging during vagus nerve stimulation. Prior to this role, he worked in the Health Technologies team at Apple Inc. on new Apple Watch hardware and health features, as well as at other large and small MedTech companies. Through his career, Trevor has gained extensive experience in physiological signal processing, with a focus on customized analysis of biomedical signals in real-time systems. He received a B.S. in Biomedical Engineering from Purdue University.

Prior to this role, Dan was CEO of Cyberonics, leading the company through a transformative period, successfully growing revenues from approximately $100 million to $300 million while advancing neuromodulation devices for epilepsy. Following the merger of Cyberonics and Sorin, Moore continued his leadership as Chairman of LivaNova, where he further expanded the company's epilepsy neuromodulation business. He brings over 35 years of experience in medical devices, with a strong focus on epilepsy treatment. He received his MBA from Boston University, and his B.A. from Harvard University.

Prior to this role, Jed was an operating partner of Elevate Ventures and has worked with numerous healthcare startups helping navigate complex reimbursement strategies and sales processes. He spent 16 years at Eli Lilly, leading a global team through internal and external cross-functional partnerships to develop and deliver core data, platforms, policies, and processes for customer-facing initiatives in 100+ affiliates. His deep understanding of market access and commercialization will be pivotal in driving Neurava's growth and market position. He received his MBA from Harvard University, and his B.S. in Mechanical Engineering from Purdue University.

Prior to this role, Mona was a member of Life Science Angels with over 20 years of leadership experience in healthcare, life sciences & biotech. She has a proven track record in strategic planning, business development, raising capital, introducing Innovative & disruptive technologies from concept to launch, successful global commercialization and managing operations across various life science companies. She received her M.S. in Microbiology from Columbia University.